A higher daily intake of vitamin D supplements was associated with better cognitive test scores among older adults with mild cognitive impairment and sleep disturbances, according to a small observational study published in Sleep Medicine.
The finding adds to growing interest in vitamin D as one possible, modifiable factor in brain health. It does not show that taking high-dose vitamin D supplements prevents dementia or reverses cognitive decline. Still, researchers say the result merits closer examination in larger clinical trials.
Dementia remains a major and expanding public-health concern. The World Health Organization estimated that about 57 million people worldwide were living with dementia in 2021. The term describes a range of conditions affecting memory, reasoning, communication and everyday independence. Alzheimer’s disease is the most common cause.
For many people, changes begin gradually. Mild cognitive impairment, often shortened to MCI, can involve memory lapses, word-finding difficulties, reduced concentration or problems with planning. MCI does not always progress to dementia. Yet it can raise the risk, particularly when symptoms worsen over time or affect daily activities.
Sleep problems may also appear early. Fragmented sleep, insomnia, sleep apnoea and excessive daytime tiredness are common in later life. They can affect attention, mood and memory in the short term. They may also be linked with long-term changes in brain health.
The new research focused on the overlap between these two issues: cognitive impairment and disturbed sleep.
Scientists recruited 54 adults, with an average age of roughly 67, who had diagnosed or suspected MCI alongside sleep difficulties. Participants reported whether they used vitamin D supplements and, if so, the amount they took each day.
The researchers then compared supplement use with performance on the Montreal Cognitive Assessment, commonly called the MoCA. This screening tool measures several aspects of cognition, including memory, attention, language, visuospatial skills and executive function. Scores can help clinicians identify possible cognitive difficulties, although they do not provide a dementia diagnosis on their own.
Participants who said they took at least 5,000 international units, or IU, of vitamin D daily scored more than 13% higher on the MoCA than those who did not take a vitamin D supplement. The difference was approximately four points.
That is an attention-grabbing result. A four-point difference on a brief cognitive screening measure could be clinically meaningful in some settings. It may reflect better performance across several thinking skills. However, the study was small and designed only to identify associations. It cannot establish that vitamin D caused the higher scores.
People who take supplements may differ from non-users in many ways. They may have better diets, more frequent medical care, higher physical activity levels, greater income, fewer untreated health conditions or other health-conscious habits. Any of these factors could contribute to stronger cognitive performance.
Researchers involved in the work stressed that the result should be interpreted carefully. The study examined a real-world group of people at a single point in time. It did not randomly assign participants to high-dose vitamin D, lower-dose vitamin D or a placebo. It also relied on self-reported supplement use, which can be imprecise.
Even so, the combination of poor sleep and MCI makes the group particularly important. Sleep and cognition are closely intertwined. A poor night’s sleep can affect concentration and memory the following day. Persistent sleep disruption may have deeper consequences.
During healthy sleep, the brain appears to carry out essential maintenance work. Research suggests that sleep supports memory consolidation, emotional regulation and the clearance of certain metabolic waste products.
Repeated disruption may increase stress responses and inflammation. It may also worsen conditions that already affect cognition, including depression, cardiovascular disease and diabetes.
Vitamin D is best known for its role in bone health. It helps the body absorb calcium and supports normal muscle function. Vitamin D also has broader biological effects. Receptors for vitamin D are found in many tissues, including the brain.
Scientists have investigated whether it may influence inflammation, immune activity, oxidative stress and nerve-cell signalling.
Those pathways offer plausible explanations for a link between vitamin D status and cognitive health. Sleep loss is associated with increased inflammatory activity. Inflammation in the nervous system, often called neuroinflammation, has been implicated in several neurodegenerative diseases. Vitamin D may help regulate some inflammatory signals, although the exact relevance to human cognition remains uncertain.
There is also evidence that vitamin D status and sleep quality may be connected. Low vitamin D levels have been associated in some studies with shorter sleep duration, poorer sleep quality and greater daytime sleepiness. The evidence is mixed. It remains unclear whether vitamin D deficiency contributes directly to sleep problems, whether sleep patterns affect vitamin D exposure and metabolism, or whether another factor explains both.
An accessible nutritional intervention would be appealing if it were shown to support cognition in people at elevated risk of decline in more studies. Vitamin D supplements are inexpensive and widely available. Yet simple availability should not be confused with proven benefit.
The wider research record on vitamin D and cognition is inconsistent by far. Some observational studies have linked low vitamin D levels with poorer memory and a higher risk of dementia. Others have found weak or no associations after accounting for age, illness, lifestyle and social factors. Clinical trials have also produced mixed outcomes.
This may be because vitamin D is most useful for people who are genuinely deficient or insufficient, rather than people whose levels are already adequate. It is also possible that vitamin D is a marker of overall health, sunlight exposure, mobility or diet rather than a direct driver of cognitive outcomes.
Sunlight remains an important source of vitamin D, though the amount produced in skin varies greatly. Season, latitude, skin tone, age, clothing, time spent outdoors and sunscreen use all affect production.
Dietary sources are relatively limited. Oily fish, such as salmon, trout, sardines and mackerel, can provide vitamin D. Egg yolks contribute smaller amounts. Some milks, plant-based alternatives, breakfast cereals, spreads and other products are fortified. Certain mushrooms exposed to ultraviolet light may contain vitamin D, although quantities vary.
For people with limited sun exposure or have sun avoidance behaviours, low dietary intake, darker skin, malabsorption conditions, obesity, kidney or liver disease, or particular medicines, testing may be appropriate in some circumstances.
A blood test measuring 25-hydroxyvitamin D is generally used to assess vitamin D status.
The new study’s 5,000 IU daily threshold requires particular caution. It should not be viewed as a general target for older adults, people with memory concerns or anyone seeking to protect their brain health. High doses may be used by clinicians to treat confirmed deficiency, though this should be tailored to the individual and monitored when needed.
The US National Institutes of Health lists 4,000 IU per day as the tolerable upper intake level for most adults from food and supplements combined. The threshold is not a recommended intake. It is the highest level unlikely to pose a risk of adverse effects for most people. Individual needs can differ, especially where medical conditions or prescribed treatment are involved.
Too much vitamin D can raise calcium levels in the blood. Severe excess can cause nausea, constipation, thirst, frequent urination, weakness, confusion, kidney stones and kidney damage. Risks may increase when high-dose supplements are taken for long periods without clinical supervision.
That does not mean people should avoid vitamin D altogether. It means the focus should be on identifying a genuine gap, then correcting it safely.
For an older person with MCI, sleep difficulties and potential vitamin D deficiency, a clinician may consider diet, lifestyle, medicines, blood tests and underlying conditions before recommending a dose.
Sleep assessment is also crucial. Snoring, gasping during sleep, witnessed pauses in breathing, morning headaches and pronounced daytime sleepiness may point to sleep apnoea. This condition is treatable and can affect cardiovascular and cognitive health. Insomnia may respond to cognitive behavioural therapy for insomnia, regular sleep scheduling, reduced evening alcohol intake, medication reviews and management of anxiety, pain or depression.
Brain health is rarely shaped by one nutrient. The strongest evidence still supports a broad approach such as regular physical activity, good blood-pressure control, diabetes management, social connection, mentally stimulating activities, avoiding smoking, limiting excess alcohol and eating a balanced diet rich in vegetables, fruit, pulses, wholegrains, fish and unsaturated fats.
For now, vitamin D looks like a promising piece of a larger puzzle, not a standalone answer to dementia risk. The study offers a useful signal in a group that deserves more attention.
Its next phase will matter most. Randomised clinical trials could determine whether vitamin D supplementation itself improves cognitive performance, whether the benefit is limited to people with deficiency, what dose is appropriate and whether any effects are sustained over time.
Until then, people concerned about memory, sleep or vitamin D should speak with a GP, pharmacist, registered dietitian or other qualified healthcare professional. A personalised assessment is safer than self-prescribing a high dose based on a headline.
The post Higher Vitamin D Intake Linked to Better Brain Health in Adults With Sleep Problems and Mild Cognitive Impairment first appeared on PP Health Malaysia.
